DiscoverNeuroFrontiersPromising Results for Investigational Antisense Oligonucleotide Treatment for Dravet Syndrome
Promising Results for Investigational Antisense Oligonucleotide Treatment for Dravet Syndrome

Promising Results for Investigational Antisense Oligonucleotide Treatment for Dravet Syndrome

Update: 2025-01-22
Share

Description

Joseph Sullivan, MD, Professor, UCSF School of Medicine, San Francisco, CA, describes encouraging results from the SWALLOWTAIL and LONGWING studies of an investigational treatment for individuals with Dravet syndrome, including outcomes related to seizure frequency, cognition, and behavior.

Comments 
In Channel
New Guidelines for the Assessment of Traumatic Brain Injury

New Guidelines for the Assessment of Traumatic Brain Injury

2025-05-0721:14

The Impact of High Efficacy DMTs on Paramagnetic Rim Lesions

The Impact of High Efficacy DMTs on Paramagnetic Rim Lesions

2025-03-2214:17

Proposed Hospital Standards for Parkinson Disease Care Aim to Avoid Preventable Harm

Proposed Hospital Standards for Parkinson Disease Care Aim to Avoid Preventable Harm

2025-03-1415:02

Promising Results for Investigational Antisense Oligonucleotide Treatment for Dravet Syndrome

Promising Results for Investigational Antisense Oligonucleotide Treatment for Dravet Syndrome

2025-01-2218:19

Vagus Nerve Stimulation: Effects Beyond the Nervous System

Vagus Nerve Stimulation: Effects Beyond the Nervous System

2024-12-1928:46

The Role of Advanced Genomic Testing in the Diagnosis and Treatment of Neurologic Conditions

The Role of Advanced Genomic Testing in the Diagnosis and Treatment of Neurologic Conditions

2024-11-2014:12

Physicians with Substance Use Disorder, Part II: Available Treatment and Recovery Options

Physicians with Substance Use Disorder, Part II: Available Treatment and Recovery Options

2024-03-2106:30

Physicians with Substance Use Disorder, Part I: Overview and A Personal Journey Through Recovery

Physicians with Substance Use Disorder, Part I: Overview and A Personal Journey Through Recovery

2024-03-0810:30

Discussing Disparities in MS Care for Underrepresented Populations

Discussing Disparities in MS Care for Underrepresented Populations

2024-01-1910:00

Google Play
Download from Google Play
Castbox
Download from App Store
usUnited States
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Promising Results for Investigational Antisense Oligonucleotide Treatment for Dravet Syndrome

Promising Results for Investigational Antisense Oligonucleotide Treatment for Dravet Syndrome

Practical Neurology